Liraglutide vs Semaglutide
Research Verdict
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
Quick Answers
Which is better, Liraglutide or Semaglutide?
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
What is the key difference between Liraglutide and Semaglutide?
Semaglutide's superior weight loss and CV data, combined with once-weekly dosing, has made liraglutide a second-choice agent in most therapeutic contexts - but liraglutide's once-daily injection may suit patients who struggle with weekly injection timing.
Evidence Comparison
Both: FDA approved, positive CVOTs (LEADER for liraglutide HR 0.87; SUSTAIN-6/SELECT for semaglutide HR 0.83/0.80). Semaglutide achieves ~15-17% weight loss (STEP trials) vs. ~8% for liraglutide (SCALE trials) - a clinically meaningful and statistically well-established difference. Once-weekly semaglutide vs. once-daily liraglutide is a practical advantage.
Evidence Context Favoring Liraglutide
When a patient or protocol specifically requires daily dosing or when there is a clinical reason to prefer a less potent GLP-1 agonist.
Evidence Context Favoring Semaglutide
Nearly all metabolic or weight management research contexts - semaglutide has greater efficacy, a broader evidence base, and more convenient dosing.
Side-by-Side Snapshot
| Evidence grade | Liraglutide: Level A Semaglutide: Level A |
|---|---|
| Research status | Liraglutide: FDA Approved Semaglutide: FDA Approved |
| Primary category | Liraglutide: Weight Loss & Metabolic Semaglutide: Weight Loss & Metabolic |
| Cited studies | Liraglutide: 2 Semaglutide: 6 |